Synthesis of 6-Chloro-1-isobutyl-3-methyl-5-nitropyrimidine-2,4(1H,3H)-dione (9): H 2 SO 4 (330 mL) was cooled to 0 ºC and added dropwise to 8- 1 (46.89 g, 216. 4 mmol) at 0 ºC. Fuming HNO 3 (26.4 g, 432.8 mmol) was added dropwise with vigorous stirring. The resultant mixture was stirred at 0 ºC for 3 h, then room temperature for 1 h. The reaction mixture was poured into ice and extracted with EA. The combined organic extracts were washed with H 2 O, sat'd NaHCO 3 , and brine, dried over Na 2 SO 4 . The solvent was removed and the residue was purified by flash column (hex:EA = 4:1) to afford 41.90 g (75%) of 9 as a yellow thick oil. R f = 0.30 
Synthesis of Methyl 2-((3-isobutyl-1-methyl-5-nitro-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-3-(naphthaene-1-yl)propanoate (11):
A mixture of 9 (1.44 g, 5.51 mmol), 10 (1.54 g, 5.78 mmol), Na 2 CO 3 (1.46 g, 13.8 mmol) in DMF (11.0 mL) was heated to 65 ºC for 2 h. The reaction mixture was cooled to room temperature, quenched with saturated NH 4 Cl, extracted with EA. The combined organic extracts were washed with brine three times and dried over Na 2 SO 4 . The solvent was removed and the residue was purified by column (hex:EA = 3:2) to afford 1.69 g (67%) of 11 as a yellow oil. R f = 0.50 (hex:EA 19.0, 19.1, 26.8, 28.4, 36.1, 53.4, 53.6, 59.8, 116.5, 122.5, 125.5, 126.2, 126.9, 128 .4,
S4
Methyl 3-(3,5-dimethyl-1-tosyl-1H-pyrazol-4-yl)-2-((3-isobutyl-1-methyl-5-nitro-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)propanoate (29-1): Follows the method for 11. yellow solid. R f = 0.15 (hex:EA = 19.5, 19.6, 27.5, 28.1, 35.1, 49.0, 56.5, 93.3, 123.1, 125.3, 126.2, 126.8, 127.9, 128.5, 129.1, 131.6, 131.8, 134.0, 138.4, 149.9, 155.5, 162 .3. 
7-((

Synthesis of 1-isobutyl-3-methyl-7-(naphthalene-1-ylmethyl)-1,5-dihydropteridine-2,4,6(3H)-trione (12):
A suspension of 11-1 (3.50 g, 8.95 mmol) in CH 3 CN (90 mL) was treated with DDQ (2.09 g, 9.22 mmol)
portionwise. The reaction mixture was stirred at room temperature for an additional 1 h. 6, 25.8, 27.5, 35.2, 48.0, 116.1, 123.7, 124.6, 124.7, 125.2, 126.5, 127.3, 131.5, 132.8, 133.0, 138.5, 149.3, 153.4, 155.2, 157.9 . 19.4, 26.6, 29.0, 36.3, 49.9, 117.0, 120.2, 122.3, 123.8, 125.5, 125.9, 126.5, 128.5, 129.0, 131.0, 132.0, 134.0, 146.1, 147.1, 150.2, 153.5, 158 
Synthesis of 1-isobutyl-
6-((2-hydroxyethyl)thio)-1-isobutyl-3-methyl-7-(naphthalen-1-ylmethyl)pteridine-2,4-(1H,3H)-dione (15c):
Follows method for 15b. (11 mL, 60%). The resultant mixture was stirred at 110 ºC for 60 h, cooled to room temperature, diluted with H 2 O, and extracted with EA. The combined organic extracts were washed with brine and dried over Na 2 SO 4 . 16.3, 19.4, 26.6, 29.0, 30.8, 39.0, 49.1, 61.3, 77.3, 98.4, 124.1, 124.5, 125.4, 125.7, 126.2, 127.9, 128.0, 128.8, 132.1, 133.2, 133.9, 134.6, 145.4, 150.4, 159 .6, 161.8. 
Synthesis of 1-isobutyl-
N-(3-((tert-butyldimethylsilyl)oxy-propyl)-1-isobutyl-N,3-dimethyl-7-(naphthalene-1-ylmethyl)-2,4-dioxo-
N-(3-hydroxypropyl)-1-isobutyl-N,3-dimethyl-7-(naphthalene-1-ylmethyl)-2,4-dioxo-1,2,3,4-
6-(4-(hydroxybut-1-yn-1-yl)-1-isobutyl-3-methyl-7-(naphthalen-1-ylmethyl)pteridine-2,4-(1H,3H)-dione (22a):
6-(4-(hydroxybutyl)-1-isobutyl-3-methyl-7-(naphthalen-1-ylmethyl)pteridine-2,4-(1H,3H)-dione (23a):
Follows method for 23b. 
6-(6-(hydroxyhexyl)-1-isobutyl-3-methyl-7-(naphthalen-1-ylmethyl)pteridine-2,4-(1H,3H)-dione (23c):
1-isobutyl-6-(5-methoxypentyl)-3-methyl-7-(naphthalen-1-ylmethyl)pteridine-2,4-(1H,3H)-dione (28):
Follows method for 23b. (m, 3H), 7.68-7.82 (m, 3H). 30 (d, J=6.8 Hz, 6H), 1.38 (sep, J=6.8 Hz, 1H), 2H), 3.13 (t, J=6.8 Hz, 2H), 3.39 (s, 3H), 3.44 (d, J=7.6 Hz, 2H), 3.71 (t, J=6.8 Hz, 2H), 5.11 (s, 2H), 4H), (m, 3H). 
Synthesis of (Z)-6-(5-(hydroxypent-1-en-1-yl)-1-isobutyl-3-methyl-7-(naphthalen-1-ylmethyl)pteridine-
2,4-(1H,3H)-dione (27):
6-(4-
(
Biological Assay Methods:
Raji lymphoma cell MTT assay. Methods used were as previously described. 4 In brief, human Raji
Burkitt lymphoma cells were seeded in 96-well plates at 20,000 cells/well and were cultured +/-compounds generated herein, or with vehicle, in 5% CO 2 incubator for 4 days. MTT reagents (Millipore CT0-A) were added at 10 l per well and cells were incubated for 5 h. 100 l Isoproponol/0.04N HCl was then added to each well, pipetted to mix, and plates were read using Biotek Synergy II plate reader at 570nm and 630nm. Experiments were performed in triplicate, and assays of the most active compounds were repeated three times. Representative data are shown in figures. EC 50 values were determined using GraphPad Prism software.
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14 C-Lactate transport assay. Methods used were as previously described. 4 Briefly, The graph represents average data from three experiments for compounds 14b, 15c, 23a, 23b, and 27. The graph represents average data from four experiments for compounds 14a and 15b. 
